Heptares Therapeutics Companies
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Industry:
Longevity FinTech
Headquarters:
United Kingdom
Employee Number:
11-50
Number Of Exists:
N/A
Founded Date:
2007